Glass Jacobson Investment Advisors llc Raises Stake in UnitedHealth Group Incorporated $UNH

Glass Jacobson Investment Advisors llc increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 80.9% during the 2nd quarter, HoldingsChannel reports. The fund owned 123 shares of the healthcare conglomerate’s stock after acquiring an additional 55 shares during the quarter. Glass Jacobson Investment Advisors llc’s holdings in UnitedHealth Group were worth $38,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Nuveen LLC purchased a new stake in UnitedHealth Group in the first quarter valued at $3,846,764,000. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP raised its stake in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. National Bank of Canada FI boosted its position in shares of UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after purchasing an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after purchasing an additional 847,054 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.6%

UnitedHealth Group stock opened at $362.78 on Monday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $328.56 billion, a PE ratio of 15.72, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock’s fifty day moving average is $338.43 and its two-hundred day moving average is $335.78.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the firm earned $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. The Goldman Sachs Group began coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price on the stock. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Truist Financial raised their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, Morgan Stanley upped their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.